Mutations in proteins allow functional innovation, but can be critically destabilizing. Recent work shows how chaperonins can rescue innovative mutants, with implications for protein engineering and adaptive evolution.
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Like hikers on a cliff edge, proteins tend to be one step away from a disastrous fall. Over evolutionary time, proteins hike in sequence space [1] , with each step corresponding to a sequence change, most often a single amino-acid substitution. Each step offers the opportunity, however unlikely, to acquire improved or novel activity, yet also carries the risk, often quite likely, of becoming unstable ( Figure 1A ), leading to misfolding and degradation. For protein engineers looking to explore new functions, and perhaps for organisms faced with a new environmental challenge, the most useful substitutions may at the same time be the most disruptive to protein stability [2, 3] . Innovation, in short, is costly. Recent work [4] suggests that this cost of innovation can be mitigated by helper proteins called chaperonins which help some of their protein clients to accumulate more, and sometimes more useful, substitutions than they could in the absence of folding assistance.
Stability to Folding to Activity
Most proteins fold with a net stability equivalent to that of a handful of hydrogen bonds or, importantly, to the effect of a single destabilizing amino acid substitution. Critically destabilized proteins cannot maintain the folded state that confers their biological activity, and tend to aggregate, often observed macroscopically as a sharp decrease in solubility. In a rare study where protein folding and function were measured independently for a large number of enzymes bearing random mutations, almost all folded proteins at least retained parental function [2] . Amino acid changes that preserve stable folding represent opportunities for functional innovation, and indeed, in the same study, a more-stable enzyme variant acquired novel functions at a far higher rate than its less-stable counterpart [2] . Conversely, when directed evolution of a fatty-acid hydroxylase toward activity on short-chain alkanes stalled, it was because the innovative mutations had destabilized the enzyme such that few, if any, additional mutations could be tolerated [5] . Stabilizing the enzyme, however, enabled the mutational march toward new substrates to resume [5] . Another way to accelerate acquisition of new protein functions would be to provide a system to buffer the effects of destabilizing mutations [2] , and chaperones offer a perfect example of such a system.
The bacterial chaperonins GroEL and GroES form a cavity in which amino-acid chains can attempt to fold while protected from the crowded intracellular milieu. About 10% of soluble Escherichia coli proteins are clients of GroEL/S [6] , which are known to suppress a wide range of mutations [7] . By performing mutationaccumulation experiments on four soluble enzymes under conditions where GroEL/S were alternately overexpressed or expressed normally, Tokuriki and Tawfik [4] demonstrated that a larger fraction of mutant proteins retained activity in the presence of high chaperonin levels than at normal levels of expression. Many of the chaperonin-compensated proteins had folding defects appearing as decreased solubility in the absence of GroEL/S. These findings suggest that the chaperonins have the potential to promote accumulation of genetic diversity.
How GroEL/S rescues mutant proteins with folding defects has been demonstrated in a series of studies by Teschke, King and colleagues [8] [9] [10] [11] . Using a set of temperature-sensitive folding (tsf) mutants of the bacteriophage P22 coat protein, a model substrate which is amenable to detailed folding studies and has a clear functional assay, they have shown that tsf substitutions that are intolerable in the absence of GroEL/S chaperonins can be rescued in the presence of the chaperonins [8] . Such rescue occurs through direct interaction between the chaperonins and the destabilized protein, preventing aggregation monitored by decreased solubility [9] . Moreover, suppressor mutations in tsf mutants facilitate the chaperonin2substrate interaction [10] , and chaperonins act to bias polypeptide flux away from aggregation of a folding intermediate and toward folding and assembly [10, 11] . Interestingly, wild-type P22 coat protein is not a GroEL/S client, whereas its tsf mutants are [8, 9] .
Rescuing Innovative Mutants
Although the P22 coat-protein work anticipates many more recent results, this system lacks a screen for functional diversification, leaving the possible functional effects of the additional mutations rescued by GroEL/S unaddressed. By contrast, enzymes have obvious diversification potential due to wide-ranging activities on different substrates. Focusing on a variant of the enzyme phosphotriesterase from Pseudomonas sp., Tokuriki and Tawfik [4] used two rounds of mutagenesis and screening in order to select phosphotriesterase mutants with improved hydrolysis activity on the chromogenic ester 2-naphthylhexanoate (2-NPH), a poor substrate for the starting enzyme. Without GroEL/S overexpression, the mutant libraries yielded an up to 3.4-fold improvement in enzymatic activity with up to a 4.2-fold higher substrate selectivity. With GroEL/S overexpression, however, mutants with an up to 44-fold higher esterase activity and a 54-fold higher selectivity were isolated. Importantly, a first-round mutation accumulated in the presence of GroEL/S overexpression conferred a nearly 12-fold improvement in esterase activity but also compromised folding, such that the amount of soluble protein decreased by 2.4-fold in the absence of chaperonin overexpression. These results identify chaperonins as a buffer for destabilizing yet functionally innovative mutations [2] , and reflect the simple idea that the major predictor of improved function in a large collection of mutant proteins is simply the number of folded polypeptides with unique sequences in that collection [12] .
The notion that chaperones could buffer evolutionarily important genetic variation, conferring 'phenotypic capacitance' in the sense of producing a consistent phenotypic output given variable genetic inputs, was introduced by Rutherford and Lindquist [13] in a study of the effects of the chaperone Hsp90 on Drosophila melanogaster morphology. In those experiments, startling lineage-specific morphological variation arose upon inhibition of Hsp90, whose clients include many transcription factors. Similar results were obtained in Arabidopsis thaliana [14] , where alleles with Hsp90-dependent phenotypes are common [15] . The evolutionary argument holds that the genotypic and resulting phenotypic variation suppressed by the chaperone could be adaptive in some environments. The chaperone's activity would thus allow a population to maintain a hidden portfolio of 'genetic wagers' which could enable faster adaptation upon environmental change -so long as such changes transiently suppress the chaperone's activity, revealing cryptic variation and, in a sense, placing previously hidden 'wagers' on the table.
The new GroEL/S overexpression study provides a molecular counterpart to the idea of morphological 'hopeful monsters' -a set of mutant proteins bearing novel mutations and, in at least one case, enhanced enzymatic activities (hope) along with structural defects (monstrosity) which require chaperonin assistance. Hsp90 workers tend to assert that the stress of a changing environment will overload or otherwise reduce the efficacy of the chaperone [15] , revealing adaptive variation, whereas Tokuriki and Tawfik [4] note that stress induces chaperone expression, allowing mutant proteins to survive and contribute adaptively with higher probability [4] . Future work must reconcile these plausible but opposing hypotheses.
The optimal method for isolating improved proteins -both during protein evolution and during directed protein design -remains an active area of study. Chaperonin overexpression [4] and pre-stabilization of proteins [2] provide alternative, and compatible, strategies for improving the yield of novel enzymes (Figure 1) . Notably, Tokuriki and Tawfik [4] report that in vitro evolution of the model proteins (and known GroEL/S clients) GFP and b-lactamase did not support the trends they observed for the four enzymes they discuss in detail. How chaperonin activity influences organismal evolution remains even more murky. But the chaperonin-facilitated molecular innovation detailed in recent studies provides tantalizing fodder for an experimental demonstration of phenotypic capacitance -the emergence of chaperone-buffered phenotypic novelty -in laboratory evolution. 
